<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Several studies have suggested a predisposing role of the e4 allele of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE) in the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we hypothesized that the e4 allele is also a risk factor for <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We attempted to assess whether Apo e4 allele is associated with <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in the early stage of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We selected 255 Chinese Han Type 2 diabtetic men without <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>PCR or allele-specific oligonucleotide probes were used to analyse ApoE genotypes, and high resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperaemia and after sublingual glyceryltrinitrate </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The flow-mediated arterial dilation among the subjects with e4/3 or e4/4 was 3.14+/-0.32%, which was lower than that in subjects with e2/2 or e3/2 (4.04+/-0.30%) ( p=0.038) </plain></SENT>
<SENT sid="6" pm="."><plain>The baseline vessel size, glyceryltrinitrate-induced arterial dilation and baseline flow were not different among different ApoE genotypes </plain></SENT>
<SENT sid="7" pm="."><plain>On univariate analysis, reduced flow-mediated arterial dilation was related to total cholesterol, <z:chebi fb="15" ids="39026">LDL</z:chebi>, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) [Lp(a)], <z:mp ids='MP_0002842'>high blood pressure</z:mp>, older age, family history of premature <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, larger vessel size, cigarette smoking, duration of <z:mp ids='MP_0002055'>diabetes</z:mp> and e4 allele ( p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>By multiple stepwise regression analysis, reduced flow-mediated arterial dilation was associated with cigarette smoking, <z:chebi fb="15" ids="39026">LDL</z:chebi>, Lp(a), and e4 allele ( p&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION/INTERPRETATION: Apo e4 allele is associated with impairment of endothelium-dependent arterial dilation in the early stage of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>